JOSHUA BEZECNY: Open Payments
NPI 1447555016 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,218 in 68 payments from 11 companies in 2025. Trend: 2023 $586 · 2024 $1,296 · 2025 $1,218
Food & beverage: $1,119Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $375 |
| GENZYME CORPORATION | 10 | $218 |
| ABBVIE INC. | 14 | $198 |
| Regeneron Healthcare Solutions, Inc. | 4 | $109 |
| Lilly USA, LLC | 3 | $89 |
| UCB, Inc. | 2 | $71 |
| Amgen Inc. | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| PFIZER INC. | 1 | $26 |
| LEO Pharma Inc. | 1 | $19 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, RINVOQ, Bimzelx, TALTZ, Otezla, LIBTAYO.
Industry payments across OR — which companies pay providers there.
